These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9339483)

  • 1. Beyond screening: problems and prospects for risk characterization of endocrine disruptors.
    Rhomberg L
    Regul Toxicol Pharmacol; 1997 Aug; 26(1 Pt 1):74-9. PubMed ID: 9339483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrine disruptor risk characterization: an EPA perspective.
    Fenner-Crisp PA
    Regul Toxicol Pharmacol; 1997 Aug; 26(1 Pt 1):70-3. PubMed ID: 9339482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-response relationships for endocrine disruptors: what we know and what we don't know.
    Lucier GW
    Regul Toxicol Pharmacol; 1997 Aug; 26(1 Pt 1):34-5. PubMed ID: 9339476
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of a Tier I screening battery for detecting endocrine-active compounds (EACs).
    Cook JC; Kaplan MA; Davis LG; O'Connor JC
    Regul Toxicol Pharmacol; 1997 Aug; 26(1 Pt 1):60-8. PubMed ID: 9339481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of endocrine disruptors: approaches, issues, and uncertainties.
    Chen CW
    Folia Histochem Cytobiol; 2001; 39 Suppl 2():20-3. PubMed ID: 11820607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A treatise on hazards of endocrine disruptors and tool to evaluate them.
    Roy P; Pereira BM
    Indian J Exp Biol; 2005 Nov; 43(11):975-92. PubMed ID: 16313061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. US panel split on endocrine disruptors..
    Macilwain C
    Nature; 1998 Oct; 395(6705):828. PubMed ID: 9804404
    [No Abstract]   [Full Text] [Related]  

  • 8. Endocrine disruptors and other food-contaminating environmental pollutants as risk factors in animal reproduction.
    Rhind SM
    Reprod Domest Anim; 2008 Jul; 43 Suppl 2():15-22. PubMed ID: 18638101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular biomarkers of endocrine disruption in small model fish.
    Scholz S; Mayer I
    Mol Cell Endocrinol; 2008 Oct; 293(1-2):57-70. PubMed ID: 18619515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A toxicologically based weight-of-evidence methodology for the relative ranking of chemicals of endocrine disruption potential.
    Calabrese EJ; Baldwin LA; Kostecki PT; Potter TL
    Regul Toxicol Pharmacol; 1997 Aug; 26(1 Pt 1):36-40. PubMed ID: 9339477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vulnerability of the endocrine system to xenobiotic influence.
    Neubert D
    Regul Toxicol Pharmacol; 1997 Aug; 26(1 Pt 1):9-29. PubMed ID: 9339474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reproducibility of endocrine disruption data.
    Ashby J; Elliott BM
    Regul Toxicol Pharmacol; 1997 Aug; 26(1 Pt 1):94-5. PubMed ID: 9339485
    [No Abstract]   [Full Text] [Related]  

  • 13. Genes may solve hormone-disrupter debate.
    Triendl R
    Nature; 2001 Jan; 409(6818):274. PubMed ID: 11201709
    [No Abstract]   [Full Text] [Related]  

  • 14. Zebrafish (Danio rerio) as a model organism for investigating endocrine disruption.
    Segner H
    Comp Biochem Physiol C Toxicol Pharmacol; 2009 Mar; 149(2):187-95. PubMed ID: 18955160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The benchmark dose method--review of available models, and recommendations for application in health risk assessment.
    Filipsson AF; Sand S; Nilsson J; Victorin K
    Crit Rev Toxicol; 2003; 33(5):505-42. PubMed ID: 14594105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Animal models of endocrine/organ-specific autoimmune diseases: do they really help us to understand human autoimmunity?
    Lam-Tse WK; Lernmark A; Drexhage HA
    Springer Semin Immunopathol; 2002 Dec; 24(3):297-321. PubMed ID: 12503056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The endocrine effects of mercury in humans and wildlife.
    Tan SW; Meiller JC; Mahaffey KR
    Crit Rev Toxicol; 2009; 39(3):228-69. PubMed ID: 19280433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards quantitative uncertainty assessment for cancer risks: central estimates and probability distributions of risk in dose-response modeling.
    Kopylev L; Chen C; White P
    Regul Toxicol Pharmacol; 2007 Dec; 49(3):203-7. PubMed ID: 17905499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine disruption in the context of life cycles: perception and transduction of environmental cues.
    Wingfield JC; Mukai M
    Gen Comp Endocrinol; 2009 Sep; 163(1-2):92-6. PubMed ID: 19416728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico tools to aid risk assessment of endocrine disrupting chemicals.
    Jacobs MN
    Toxicology; 2004 Dec; 205(1-2):43-53. PubMed ID: 15458789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.